This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease
|
|
information resource reference
|
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2023 03 28; 7(6):963-970.
|
|
label
|
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
|
- Stem Cell Transplantation Hematopoietic